Abstract
Vitronectin (VN) and pro-urokinase (pro-uPA) stimulated migration of rat smooth muscle cells in a dose-dependent and additive way, and induced motile-type changes in cell morphology together with a complete reorganization of the actin filaments and of the microtubules. All these effects were inhibited by pertussis toxin, or by antibodies directed against the urokinase receptor (uPAR) or against the VN receptor αvβ3 suggesting that an association between the two receptors is required to mediate both signals. Investigation of the signaling pathways showed that increasing the intracellular cAMP resulted in a selective inhibition of VN-induced cell migration. On the other hand, PD 98059, an inhibitor of MEK, differentially inhibited the pro-uPA- but not the VN-induced cell migration. Phosphorylation and nuclear translocation of Erk by pro-uPA was directly observed. We conclude that the signaling pathways of pro-uPA and VN must be at least in part different.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- PI-3K:
-
phosphatidylinositol-3 kinase
- PK-A:
-
protein kinase A
- PK-C:
-
protein kinase C
- pro-uPA:
-
pro-urokinase
- PT:
-
pertussis toxin
- RSMC:
-
rat smooth muscle cells
- uPA:
-
urokinase
- uPAR:
-
urokinase receptor
- VN:
-
vitronectin.
References
Aguirre Ghiso JA, Kovalski K, Ossowski L . 1999 J. Cell Biol. 147: 89–104
Behrendt N, Ploug M, Patthy L, Houen G, Blasi F, Danø K . 1991 J. Biol. Chem. 266: 7842–7847
Bilato C, Curto KA, Monticone RE, Pauly RR, White AJ, Crow MT . 1997 J. Clin. Invest. 100: 693–704
Blasi F . 1997 Immunol. Today 18: 415–417
Bohuslav J, Horejsi V, Hansmann C, Stockl J, Weidle UH, Majdic O, Bartke I, Knapp W, Stockinger H . 1995 J. Exp. Med. 181: 1381–1390
Boulay F, Tardif M, Brouchon L, Vignais P . 1990 Biochemistry 29: 11123–11133
Boyle MDP, Chiodo VA, Lawman MJP, Gee AP, Young M . 1987 J. Immunol. 139: 169–174
Brown SL, Lundgren CH, Nordt T, Fujii S . 1994 Cardiovasc. Res. 28: 1815–1820
Byzova TV, Rabbani R, D'Souza SE, Plow EF . 1998 Thromb Haemost. 80: 726–734
Carriero MV, Del Vecchio S, Capozzoli M, Franco P, Fontana L, Zannetti A, Botti G, D'Aiuto G, Salvatore M, Stoppelli MP . 1999 Cancer Res. 59: 5307–5314
Chapman HA . 1997 Curr. Opin. Cell Biol. 9: 714–724
Chavakis T, Kanse SM, Yutzy B, Lijnen HR, Preissner KT . 1998 Blood 7: 2305–2312
Choi ET, Engel L, Callow AD, Sun S, Trachtenberg J, Santoro S, Ryan US . 1994 J. Vasc. Surg. 19: 125–134
Ciambrone GJ, McKeown-Longo PJ . 1992 J. Biol. Chem. 267: 13617–13622
Clyman RI, Mauray F, Kramer RH . 1992 Exp. Cell Res. 200: 272–284
Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA, Glieman J, Christensen EI, Blasi F . 1995 J. Cell Biol. 131: 1609–1622
Degryse B, Resnati M, Rabbani SA, Villa A, Fazioli F, Blasi F . 1999 Blood 94: 649–662
Del Rosso M, Pedersen N, Fibbi G, Pucci M, Dini G, Anichini E, Blasi F . 1992 Experim. Cell Res. 203: 427–434
Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ . 1996 J. Cell Biol. 134: 1563–1571
Dumler I, Kopmann A, Wagner K, Mayboroda OA, Jerke U, Dietz R, Haller H, Gulba DC . 1999 J. Biol. Chem. 274: 24059–24065
Fazioli F, Resnati M, Sidenius N, Higashimoto Y, Appella E, Blasi F . 1997 EMBO J. 16: 7279–7286
Fibbi G, Ziche M, Morbidelli L, Magnelli L, Del Rosso M . 1988 Exp. Cell Res. 179: 385–395
Graves LM, Lawrence Jr JC . 1996 Trends Endocrinol. Metabol. 7: 43–50
Gudewicz PW, Bilboa N . 1987 Biochem. Biophys. Res. Comm. 147: 1176–1181
Gyetko MR, Chen GH, McDonald RA, Goodman R, Huffnagle GB, Wilkinson CC, Fuller JA, Toews GB . 1996 J. Clin. Invest. 97: 1818–1826
Howe AK, Juliano RL . 2000 Nature Cell Biol. 2: 593–600
Høyer-Hansen G, Ploug M, Behrendt N, Rønne E, Danø K . 1997 Eur. J. Biochem. 243: 21–26
Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT . 1996 Exp. Cell Res. 224: 344–353
Kapeller R, Cantley LC . 1994 BioEssays 16: 565–576
Kjoeller L, Kanse SM, Kirkegaard T, Rodenburg KW, Rønne E, Goodman SL, Preissner KT, Ossowski L, Andreasen PA . 1997 Exp. Cell Res. 232: 420–429
Konakova M, Hucho F, Schleuning WD . 1998 Eur. J. Biochem. 253: 421–429
Kusch A, Tkachuck S, Haller H, Dietz R, Gulba DC, Lipp M, Dumler I . 2000 J. Biol. Chem. 275: 39466–39473
Lin TH, Chen Q, Howe A, Juliano RL . 1997 J. Biol. Chem. 272: 8849–8852
May AE, Kanse SM, Lund LR, Gisler RH, Imhof BA, Preissner KT . 1998 J. Exp. Med. 188: 1029–1037
Miyamoto S, Teramoto H, Gutkind JS, Yamada KM . 1996 J. Cell Biol. 135: 1633–1642
Nguyen DH, Hussaini IM, Gonias SL . 1998 J. Biol. Chem. 273: 8502–8507
Nguyen D, Catling AD, Webb DJ, Sankovic M, Walker LA, Somlyo AV, Weber MJ, Gonias SL . 1999 J. Cell Biol. 146: 149–164
Nguyen DH, Webb DJ, Catling AD, Song Q, Dhakephalkar A, Weber MJ, Ravichandran KS, Gonias SL . 2000 J. Biol. Chem. 275: 19382–19388
Ossowski L, Aguirre Ghiso JA . 2000 Curr. Opin. Cell Biol. 12: 613–620
Ploug M, Ellis V, Danø K . 1994 Biochemistry 33: 8991–8997
Preissner K, Seiffert D . 1998 Thromb. Res. 89: 1–21
Renshaw MW, Ren XD, Schwartz MA . 1997 EMBO J. 16: 5592–5599
Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F . 1996 EMBO J. 15: 1572–1582
Schoenwaelder SM, Burridge K . 1999 Curr. Opin. Cell Biol. 11: 274–286
Sidenius N, Blasi F . 2000 FEBS Lett. 470: 40–46
Simon DI, Rao NK, Xu H, Wei Y, Majdic O, Rønne E, Kobzik L, Chapman Jr HA . 1996 Blood 88: 3185–3194
Simon DI, Wei Y, Zhang L, Rao NK, Xu H, Chen Z, Liu Q, Rosenberg S, Chapman HA . 2000 J. Biol. Chem. 275: 10228–10234
Slepian MJ, Massia SP, Dehdashti B, Fritz A, Whitesell L . 1998 Circulation 97: 1818–1827
Stahl A, Mueller BM . 1997 Int. J. Cancer 71: 116–122
Stefansson S, Lawrence DA . 1996 Nature 383: 441–443
Tarui T, Mazar AP, Cines DB, Takada Y . 2000 J. Biol. Chem. 276: 3938–3990
Waltz DA, Chapman HA . 1994 J. Biol. Chem. 269: 14746–14750
Webb DJ, Nguyen DH, Gonias SL . 2000 J. Cell. Sci. 113: 123–134
Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA . 1994 J. Biol. Chem. 269: 32380–32388
Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA . 1996 Science 273: 1551–1555
Xue W, Mizukami I, Todd III RF, Petty HR . 1997 Cancer Res. 57: 1682–1689
Yatohgo T, Izumi M, Kashiwagi H, Hayashi M . 1988 Cell Struct. Funct. 13: 281–292
Yebra M, Parry GCN, Stromblad S, Mackman N, Rosenberg S, Mueller BM, Cheresh DA . 1996 J. Biol. Chem. 271: 29393–29399
Acknowledgements
The authors thank Drs M Bertulli and MG Pizza for providing cells and reagents. We are very grateful to Drs N Johanson and A Mondino for helpful advice and comments. Supported by grants of the Italian Association for Cancer Research (AIRC), the Italian Ministry of University and of Scientific and Technological Research (MURST, PRIN 99), the Istituto Superiore di Sanità and the EU Fifth Framework Program (Contract QLG1-CT-2000-01131).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Degryse, B., Orlando, S., Resnati, M. et al. Urokinase/urokinase receptor and vitronectin/αvβ3 integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways. Oncogene 20, 2032–2043 (2001). https://doi.org/10.1038/sj.onc.1204261
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204261
Keywords
This article is cited by
-
D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR
Cellular and Molecular Life Sciences (2018)
-
Differences in integrin expression and signaling within human breast cancer cells
BMC Cancer (2011)
-
uPA/PAI-1 expression and uPA promoter methylation in meningiomas
Journal of Neuro-Oncology (2011)
-
Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-κB-dependent activation of the urokinase plasminogen activator system
British Journal of Cancer (2009)
-
Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling
Clinical & Experimental Metastasis (2007)